Wellington Partners

Dr Thomas Widmann and Professor Erich Schlick will be augmenting the Wellington Partners life science team as further general partners. Cardiologist Widmann formed his first company, Triton Technology, in San Diego back in the early 1980s. He then went on to head up global development of new cardiovascular products at Roche for eight years. In 1996, he formed clinical research organization Hesperion. Today, this profitable company, which has been a member of the Cerep Group since 2003, employs 150 people throughout the world. He and two colleagues then founded Actelion in 1997. The entrepreneur has already been successfully supporting the Wellington Life Science team for the past two years as a venture partner, including serving as the chairman of Wellington Partners portfolio company immatics in Tübingen, Germany. In the second half of 2005, Professor Erich Schlick will also be augmenting Wellington's Life Science competence as a general partner. Schlick has served as the director of 3i Germany's healthcare division for more than four years. Prior to that, as a member of top management at BASF Pharma he played a key role in research and development activities in connection with the world's first fully human monoclonal TNF antibody.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• DACH
• Healthcare